Correlation Between Day One and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Day One and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Day One and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Biomarin Pharmaceutical.
Diversification Opportunities for Day One and Biomarin Pharmaceutical
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Day and Biomarin is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Day One i.e., Day One and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Day One and Biomarin Pharmaceutical
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 1.84 times more return on investment than Biomarin Pharmaceutical. However, Day One is 1.84 times more volatile than Biomarin Pharmaceutical. It trades about -0.1 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.28 per unit of risk. If you would invest 1,433 in Day One Biopharmaceuticals on August 24, 2024 and sell it today you would lose (99.00) from holding Day One Biopharmaceuticals or give up 6.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Day One Biopharmaceu |
| Biomarin Pharmaceutical |
Day One and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Biomarin Pharmaceutical
The main advantage of trading using opposite Day One and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Day One vs. Lyra Therapeutics | Day One vs. Hookipa Pharma | Day One vs. Cingulate Warrants | Day One vs. SAB Biotherapeutics |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |